Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions.

Culas, Roshni; Nath, Sridesh; Nath, Sarath

Culas, Roshni; Nath, Sridesh; Nath, Sarath.

Culas R; Division of Infectious Disease, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Nath S; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Nath S; Division of Infectious Diseases, Department of Medicine, Stony Brook University Hospital, Stony Brook, New York.

JAMA Intern Med ; 183(4): 362-363, 2023 04 01.

Article in English | MEDLINE | ID: covidwho-2289436

This Teachable Moment discusses drug-drug interactions with nirmatrelvir and ritonavir (Paxlovid) treatment for COVID-19 and considerations when prescribing.

Subject(s)

Lactams; Ritonavir; Humans; Ritonavir/therapeutic use; Nitriles; Antiviral Agents

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ritonavir / Lactams Limits: Humans Language: English Journal: JAMA Intern Med Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google